"Mobile Medical Applications"
Drucker says its important to acknowledge when GLP-1s fall short in clinical trials
The FDA has voiced concerns about pharmacies using unapproved ingredients, improper labeling, and a lack of quality control
In fact, high-profile examples of payers pulling back on coverage are stacking up: North Carolinas state health plan dropped GLP-1s after spending $100 million, Ascension eliminated all weight-loss drug coverage, and Mayo Clinic capped lifetime GLP-1 benefits at $20,000
It can also worsen potential side effects such as nausea, dehydration, or digestive discomfort
Fecal microbiota transplantation ameliorates high-fat diet-induced memory impairment in mice